01 / Therapeutic Dermatology
A Peptide-Drug Conjugate for Androgenetic Alopecia
N1 partnered with a pharmaceutical company to develop a novel Class 1 drug program for androgenetic alopecia. The program applies a peptide-drug conjugate to enable transdermal delivery of the active to its target tissue in skin.